Balance Sheet Pets at Home Group Plc

Equities

PETS

GB00BJ62K685

Other Specialty Retailers

Real-time Estimate Cboe Europe Other stock markets 16:01:53 12/02/2026 GMT			5-day change	1st Jan Change
218.90 ^GBX	+1.06%		+1.20%	+10.71%

01-28	London's FTSE 100 falls as investors rotate into US tech stocks ahead of Fed decision	RE
01-28	London's FTSE 100 falls as healthcare, bank stocks decline	RE

0fb9430586415c1303.sSYJZ2G8URS-BQtgM-N0tDzjsrW8JZi7iP2chNg0nVU.3W89CDXvYl_6X3ozXo4m_XuW5_veV_nqxZPo_olt0wzpSW0wM_owUthjXg

Published financial data: PETS AT HOME GROUP PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1.14B	1.32B	1.4B	1.48B	1.48B
Total Revenues	1.14B	1.32B	1.4B	1.48B	1.48B
Cost of Goods Sold, Total	583M	671M	738M	785M	787M
Gross Profit	560M	647M	666M	691M	695M
Selling General & Admin Expenses, Total	455M	503M	537M	572M	564M
Provision for Bad Debts	800K	-700K	-2M	-	-
Other Operating Expenses	-	-	-12.2M	-12.7M	-14.6M
Other Operating Expenses, Total	456M	503M	523M	560M	549M
Operating Income	104M	144M	144M	132M	146M
Interest Expense, Total	-18.7M	-15.3M	-17M	-17.6M	-18.7M
Interest And Investment Income	300K	200K	2.7M	4M	2.9M
Net Interest Expenses	-18.4M	-15.1M	-14.3M	-13.6M	-15.8M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	85.6M	129M	129M	118M	130M
Restructuring Charges	600K	-	-6.6M	-11.4M	-11.4M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	2.3M
Gain (Loss) On Sale Of Assets	30.2M	19.2M	-	-	-
Asset Writedown	-	100K	-	-	-
Legal Settlements	-	-	-	-900K	-
Other Unusual Items	-	-	-100K	-	-
EBT, Incl. Unusual Items	116M	149M	122M	106M	121M
Income Tax Expense	17.4M	24.2M	21.8M	26.5M	32.4M
Earnings From Continuing Operations	99M	124M	101M	79.2M	88.2M
Net Income to Company	99M	124M	101M	79.2M	88.2M
Net Income - (IS)	99M	124M	101M	79.2M	88.2M
Net Income to Common Incl Extra Items	99M	124M	101M	79.2M	88.2M
Net Income to Common Excl. Extra Items	99M	124M	101M	79.2M	88.2M
Per Share Items
Net EPS - Basic	0.2	0.25	0.2	0.17	0.19
Basic EPS - Continuing Operations	0.2	0.25	0.2	0.17	0.19
Basic Weighted Average Shares Outstanding	500M	500M	492M	478M	464M
Net EPS - Diluted	0.19	0.24	0.2	0.16	0.19
Diluted EPS - Continuing Operations	0.19	0.24	0.2	0.16	0.19
Diluted Weighted Average Shares Outstanding	512M	507M	498M	483M	468M
Normalized Basic EPS	0.11	0.16	0.16	0.15	0.17
Normalized Diluted EPS	0.1	0.16	0.16	0.15	0.17
Dividend Per Share	0.08	0.12	0.13	0.13	0.13
Payout Ratio	37.47	38.96	58.29	76.64	67.69
Supplemental Items
EBITDA	131M	171M	170M	158M	174M
EBITA	104M	145M	144M	132M	146M
EBIT	104M	144M	144M	132M	146M
EBITDAR	131M	171M	170M	-	-
Effective Tax Rate - (Ratio)	14.95	16.27	17.8	25.07	26.87
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	18.4M	23M	23.3M	21.3M	19.3M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-1M	1.2M	-1.5M	5.2M	13.1M
Normalized Net Income	53.5M	80.88M	80.75M	73.75M	81.06M
Interest on Long-Term Debt	18.8M	15.3M	17M	17.6M	17.9M
Supplemental Operating Expense Items
Selling and Marketing Expenses	321M	382M	416M	455M	443M
General and Administrative Expenses	134M	121M	121M	117M	121M
Net Rental Expense, Total	100K	100K	100K	-	-
Imputed Operating Lease Interest Expense	26.25K	24.73K	26.61K	-	-
Imputed Operating Lease Depreciation	73.75K	75.27K	73.39K	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	4.7M	4.9M	4.9M	5.9M	5.9M
Total Stock-Based Compensation	4.7M	4.9M	4.9M	5.9M	5.9M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	101M	166M	178M	57.1M	39.5M
Trading Asset Securities, Total	-	-	2M	-	-
Total Cash And Short Term Investments	101M	166M	180M	57.1M	39.5M
Accounts Receivable, Total	11.4M	14.9M	13.5M	24.8M	30.7M
Other Receivables	17.2M	31.3M	13.2M	20.6M	19M
Notes Receivable	20.5M	15.2M	10.4M	5.8M	3.9M
Total Receivables	49.1M	61.4M	37.1M	51.2M	53.6M
Inventory	83.7M	84.5M	109M	97.5M	107M
Prepaid Expenses	500K	1.7M	3.4M	9.3M	9.9M
Deferred Tax Assets Current	2.9M	1.1M	-	-	-
Other Current Assets, Total	1.2M	2.7M	11.5M	700K	500K
Total Current Assets	239M	317M	341M	216M	210M
Gross Property Plant And Equipment	818M	891M	1.04B	1.11B	1.12B
Accumulated Depreciation	-350M	-442M	-534M	-630M	-672M
Net Property Plant And Equipment	468M	449M	506M	477M	446M
Long-term Investments	1.5M	2.9M	2.5M	4.7M	5.7M
Goodwill	958M	959M	959M	959M	959M
Other Intangibles, Total	41.8M	28.1M	30.3M	20.3M	25.8M
Loans Receivable Long-Term	14.6M	10.7M	7.8M	5.7M	3.9M
Deferred Tax Assets Long-Term	-	-	1.9M	-	-
Other Long-Term Assets, Total	600K	500K	600K	500K	5.4M
Total Assets	1.72B	1.77B	1.85B	1.68B	1.66B
Liabilities
Accounts Payable, Total	125M	128M	160M	139M	147M
Accrued Expenses, Total	56.7M	60.5M	66.1M	73.2M	71.1M
Current Portion of Long-Term Debt	100K	-	1.2M	2.2M	4.7M
Current Portion of Leases	78.4M	78.3M	83.3M	79.8M	78.5M
Current Income Taxes Payable	1.5M	-	-	1.4M	-
Unearned Revenue Current, Total	1.2M	2.3M	2.4M	1.7M	2.2M
Other Current Liabilities	34M	40.8M	40.6M	43.9M	42.4M
Total Current Liabilities	297M	310M	354M	341M	346M
Long-Term Debt	100M	96.9M	120M	43.3M	26.7M
Long-Term Leases	331M	305M	338M	301M	270M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	-	-	-	4.7M	17.6M
Other Non Current Liabilities	2.1M	6.7M	12.9M	5.1M	3.9M
Total Liabilities	730M	718M	824M	695M	664M
Common Stock, Total	5M	5M	4.8M	4.7M	4.6M
Retained Earnings	1.25B	1.3B	1.28B	1.24B	1.25B
Comprehensive Income and Other	-260M	-255M	-260M	-259M	-260M
Total Common Equity	994M	1.05B	1.03B	988M	993M
Total Equity	994M	1.05B	1.03B	988M	993M
Total Liabilities And Equity	1.72B	1.77B	1.85B	1.68B	1.66B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	494M	497M	478M	462M	454M
ECS Total Common Shares Outstanding	494M	497M	478M	462M	454M
Book Value / Share	2.01	2.11	2.15	2.14	2.19
Tangible Book Value	-6.5M	62.6M	35.6M	8.8M	8.1M
Tangible Book Value Per Share	-0.01	0.13	0.07	0.02	0.02
Total Debt	510M	480M	542M	426M	380M
Net Debt	409M	314M	362M	369M	340M
Debt Equivalent Oper. Leases	800K	800K	800K	-	-
Equity Method Investments, Total	200K	200K	400K	2.7M	2.7M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	87.6M	88.4M	113M	102M	111M
Machinery, Total	245M	262M	296M	345M	358M
Full Time Employees	10K	10.26K	11.38K	12.03K	11.6K

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	99M	124M	101M	79.2M	88.2M
Depreciation & Amortization - CF	97.2M	95.1M	93.6M	91.6M	89M
Amortization of Goodwill and Intangible Assets - (CF)	200K	700K	700K	200K	200K
Depreciation & Amortization, Total	97.4M	95.8M	94.3M	91.8M	89.2M
Amortization of Deferred Charges, Total - (CF)	13.4M	8.1M	9.1M	9.9M	8.7M
(Gain) Loss From Sale Of Asset	-30.2M	-19.2M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-2.3M
Asset Writedown & Restructuring Costs	-	-	-	7.9M	5.1M
Stock-Based Compensation (CF)	4.7M	4.9M	4.9M	5.9M	5.9M
Other Operating Activities, Total	18.3M	7.6M	22.4M	19.9M	26.5M
Change In Accounts Receivable	3.1M	600K	3.4M	-6.3M	-900K
Change In Inventories	-22.1M	-800K	-24.1M	11.1M	-9.4M
Change In Accounts Payable	10.2M	19.8M	36.9M	-5.3M	10.7M
Change in Other Net Operating Assets	1.3M	6.8M	3.6M	-4.1M	-3.7M
Cash from Operations	195M	248M	251M	210M	218M
Capital Expenditure	-34.9M	-55.5M	-75.7M	-48M	-49M
Sale of Property, Plant, and Equipment	300K	300K	-	-	-
Cash Acquisitions	-16.9M	-1.7M	-500K	-1M	-1.3M
Divestitures	79.4M	19.8M	400K	-1.5M	-1.6M
Investment in Marketable and Equity Securities, Total	-	-	-	-3.5M	400K
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	2.1M	1.5M
Other Investing Activities, Total	0	0	800K	3.6M	2.6M
Cash from Investing	27.9M	-37.1M	-75M	-48.3M	-47.4M
Long-Term Debt Issued, Total	60M	100M	123M	-	-
Total Debt Issued	60M	100M	123M	-	-
Long-Term Debt Repaid, Total	-192M	-167M	-169M	-143M	-81.5M
Total Debt Repaid	-192M	-167M	-169M	-143M	-81.5M
Repurchase of Common Stock	-8.7M	-12.3M	-64.4M	-61.1M	-29M
Common Dividends Paid	-37.1M	-48.5M	-58.7M	-60.7M	-59.7M
Common & Preferred Stock Dividends Paid	-37.1M	-48.5M	-58.7M	-60.7M	-59.7M
Other Financing Activities, Total	-23.3M	-18.3M	4.5M	-17.4M	-18M
Cash from Financing	-201M	-146M	-164M	-283M	-188M
Net Change in Cash	22.3M	64.6M	12M	-121M	-17.6M
Supplemental Items
Cash Interest Paid	17.6M	15M	17.4M	16.5M	18M
Cash Income Tax Paid (Refund)	17.5M	31M	13.7M	20.2M	20.9M
Levered Free Cash Flow	132M	137M	139M	123M	125M
Unlevered Free Cash Flow	143M	146M	150M	134M	136M
Change In Net Working Capital	2.2M	-2.7M	-27.5M	8M	9M
Net Debt Issued / Repaid	-132M	-67.3M	-45.6M	-143M	-81.5M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.72	5.2	4.96	4.66	5.44
Return on Total Capital	4.24	5.99	5.79	5.52	6.52
Return On Equity %	10.29	12.29	9.71	7.87	8.9
Return on Common Equity	10.29	12.29	9.71	7.87	8.9
Margin Analysis
Gross Profit Margin %	48.97	49.11	47.45	46.82	46.87
SG&A Margin	39.8	38.2	38.24	38.76	38.04
EBITDA Margin %	11.47	12.95	12.13	10.72	11.75
EBITA Margin %	9.12	11.02	10.27	8.93	9.83
EBIT Margin %	9.1	10.97	10.22	8.91	9.82
Income From Continuing Operations Margin %	8.66	9.45	7.17	5.36	5.95
Net Income Margin %	8.66	9.45	7.17	5.36	5.95
Net Avail. For Common Margin %	8.66	9.45	7.17	5.36	5.95
Normalized Net Income Margin	4.68	6.14	5.75	4.99	5.47
Levered Free Cash Flow Margin	11.53	10.38	9.91	8.32	8.44
Unlevered Free Cash Flow Margin	12.55	11.1	10.67	9.06	9.17
Asset Turnover
Asset Turnover	0.65	0.76	0.78	0.84	0.89
Fixed Assets Turnover	2.26	2.87	2.94	3	3.21
Receivables Turnover (Average Receivables)	79.36	100.21	98.89	59.3	53.41
Inventory Turnover (Average Inventory)	7.96	7.97	7.64	7.62	7.7
Short Term Liquidity
Current Ratio	0.81	1.03	0.96	0.63	0.61
Quick Ratio	0.44	0.69	0.58	0.3	0.26
Operating Cash Flow to Current Liabilities	0.66	0.8	0.71	0.62	0.63
Days Sales Outstanding (Average Receivables)	4.59	3.7	3.68	6.14	6.82
Days Outstanding Inventory (Average Inventory)	45.72	46.53	47.63	47.77	47.25
Average Days Payable Outstanding	72.97	69.74	68.72	70.29	65.26
Cash Conversion Cycle (Average Days)	-22.66	-19.51	-17.41	-16.39	-11.2
Long Term Solvency
Total Debt/Equity	51.33	45.72	52.9	43.13	38.23
Total Debt / Total Capital	33.92	31.37	34.6	30.13	27.66
LT Debt/Equity	43.43	38.26	44.66	34.83	29.85
Long-Term Debt / Total Capital	28.7	26.26	29.21	24.34	21.6
Total Liabilities / Total Assets	42.36	40.61	44.57	41.29	40.05
EBIT / Interest Expense	5.56	9.44	8.44	7.48	7.78
EBITDA / Interest Expense	10.77	15.71	13.99	12.69	12.55
(EBITDA - Capex) / Interest Expense	8.9	12.08	9.54	9.97	9.93
Total Debt / EBITDA	2.53	2	2.28	1.91	1.62
Net Debt / EBITDA	2.03	1.31	1.52	1.65	1.45
Total Debt / (EBITDA - Capex)	3.06	2.6	3.35	2.43	2.04
Net Debt / (EBITDA - Capex)	2.45	1.7	2.24	2.1	1.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.93	15.31	6.56	5.16	0.13
Gross Profit, 1 Yr. Growth %	7.86	15.65	2.95	2.48	0.49
EBITDA, 1 Yr. Growth %	-5.75	41.23	-0.18	-6.83	1.81
EBITA, 1 Yr. Growth %	-5.96	54.3	-0.69	-8.6	0.76
EBIT, 1 Yr. Growth %	-5.97	53.89	-0.69	-8.29	0.76
Earnings From Cont. Operations, 1 Yr. Growth %	46.88	37.72	-19.12	-21.35	11.36
Net Income, 1 Yr. Growth %	46.88	37.72	-19.12	-21.35	11.36
Normalized Net Income, 1 Yr. Growth %	-7.76	71.39	-0.15	-8.67	-0.84
Diluted EPS Before Extra, 1 Yr. Growth %	46.97	38.42	-17.55	-18.81	14.63
Accounts Receivable, 1 Yr. Growth %	-34.48	30.7	-9.4	-0.8	23.79
Inventory, 1 Yr. Growth %	33.28	0.96	28.52	-10.22	9.64
Net Property, Plant and Equip., 1 Yr. Growth %	-13.65	-4.12	12.81	-5.75	-6.51
Total Assets, 1 Yr. Growth %	-2.54	3.65	4.63	-8.95	-1.6
Tangible Book Value, 1 Yr. Growth %	-91.38	-2.19K	-43.13	-75.28	-7.95
Common Equity, 1 Yr. Growth %	6.73	7.5	-2.34	-3.57	0.48
Cash From Operations, 1 Yr. Growth %	-9.34	36.77	1.25	-16.4	3.81
Capital Expenditures, 1 Yr. Growth %	-11.87	161.79	36.4	-36.59	2.08
Levered Free Cash Flow, 1 Yr. Growth %	-2.28	5.08	0.95	-11.02	-5.01
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.93	3.12	1.61	-9.98	-4.17
Dividend Per Share, 1 Yr. Growth %	6.67	47.5	8.47	0	1.56
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.05	11.56	10.85	5.85	2.74
Gross Profit, 2 Yr. CAGR %	6.89	11.69	9.12	3.35	1.48
EBITDA, 2 Yr. CAGR %	12.17	10.75	18.73	-3.67	1.26
EBITA, 2 Yr. CAGR %	17.32	14.48	23.79	-4.73	0.52
EBIT, 2 Yr. CAGR %	17.29	14.3	23.62	-4.57	0.69
Earnings From Cont. Operations, 2 Yr. CAGR %	80.16	35.91	5.54	-20.24	-6.41
Net Income, 2 Yr. CAGR %	80.16	35.91	5.54	-20.24	-6.41
Normalized Net Income, 2 Yr. CAGR %	8.96	18.08	30.82	-4.51	0.19
Diluted EPS Before Extra, 2 Yr. CAGR %	79.81	36.24	6.83	-18.18	-3.53
Accounts Receivable, 2 Yr. CAGR %	-15.06	-7.46	8.82	29.01	10.82
Inventory, 2 Yr. CAGR %	10.78	16	13.91	7.42	-0.79
Net Property, Plant and Equip., 2 Yr. CAGR %	94.57	-9.01	4	3.11	-6.13
Total Assets, 2 Yr. CAGR %	13.33	-0.04	4.14	-2.4	-5.35
Tangible Book Value, 2 Yr. CAGR %	-74.21	-8.88	244.48	-62.51	-52.3
Common Equity, 2 Yr. CAGR %	4.9	6.18	2.46	-2.96	-1.57
Cash From Operations, 2 Yr. CAGR %	34.53	7.37	17.68	-8	-6.84
Capital Expenditures, 2 Yr. CAGR %	-3.4	18.39	88.96	-7	-19.55
Levered Free Cash Flow, 2 Yr. CAGR %	31.56	0.73	3.41	-5.6	-4.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	35.02	0.03	2.75	-4.71	-4.38
Dividend Per Share, 2 Yr. CAGR %	3.28	25.43	26.49	4.15	0.78
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.33	11.1	9.87	8.92	3.99
Gross Profit, 3 Yr. CAGR %	5.97	9.73	8.7	7.3	2.39
EBITDA, 3 Yr. CAGR %	5.13	17.86	6.98	9.43	0.7
EBITA, 3 Yr. CAGR %	7.21	24.25	9.18	11.89	0.11
EBIT, 3 Yr. CAGR %	7.18	24.1	9.07	11.91	0.23
Earnings From Cont. Operations, 3 Yr. CAGR %	16.38	59.82	14.32	-4.31	-10.85
Net Income, 3 Yr. CAGR %	16.38	59.82	14.32	-4.31	-10.85
Normalized Net Income, 3 Yr. CAGR %	2.2	21.53	11.66	16.05	0.08
Diluted EPS Before Extra, 3 Yr. CAGR %	15.59	59.83	15.24	-2.51	-8.45
Accounts Receivable, 3 Yr. CAGR %	-7.94	-1.94	-8.11	29.57	27.25
Inventory, 3 Yr. CAGR %	11.41	7.4	20.03	5.22	8.15
Net Property, Plant and Equip., 3 Yr. CAGR %	53.33	53.68	-2.25	0.64	-0.2
Total Assets, 3 Yr. CAGR %	8.78	9.61	1.49	-0.42	-2.13
Tangible Book Value, 3 Yr. CAGR %	-57.81	-13.79	-22.13	43.15	-49.42
Common Equity, 3 Yr. CAGR %	3.11	5.15	3.26	0.41	-1.83
Cash From Operations, 3 Yr. CAGR %	21.89	32.03	5.29	5	-4.22
Capital Expenditures, 3 Yr. CAGR %	-5.7	14.06	24.11	31.31	-4.07
Levered Free Cash Flow, 3 Yr. CAGR %	39.63	21.58	1.07	-1.9	-3.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	40.7	22.98	0.81	-1.93	-2.67
Dividend Per Share, 3 Yr. CAGR %	2.17	16.31	19.5	16.96	3.28
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.58	9.58	9.33	8.97	6.96
Gross Profit, 5 Yr. CAGR %	5.29	7.45	7.22	7.13	6.01
EBITDA, 5 Yr. CAGR %	1.09	6.3	8.58	8.72	4.6
EBITA, 5 Yr. CAGR %	0.38	7.75	11.27	11.73	5.63
EBIT, 5 Yr. CAGR %	0.34	7.66	11.18	11.72	5.64
Earnings From Cont. Operations, 5 Yr. CAGR %	6.35	10.56	9.9	21.03	5.53
Net Income, 5 Yr. CAGR %	6.35	10.56	9.9	21.03	5.53
Normalized Net Income, 5 Yr. CAGR %	-2.53	6.29	10.01	10.35	6.92
Diluted EPS Before Extra, 5 Yr. CAGR %	6	10.31	9.96	22.28	7.33
Accounts Receivable, 5 Yr. CAGR %	-6.75	-1.38	-1.57	9.44	12.03
Inventory, 5 Yr. CAGR %	9.79	8.41	12.4	7.41	11.23
Net Property, Plant and Equip., 5 Yr. CAGR %	32.48	28.36	31.28	31.01	-3.82
Total Assets, 5 Yr. CAGR %	6.61	6.01	6.67	4.64	-1.3
Tangible Book Value, 5 Yr. CAGR %	-45.08	-10.27	-16.28	-38.21	-35.99
Common Equity, 5 Yr. CAGR %	3.33	3.53	2.49	1.83	1.3
Cash From Operations, 5 Yr. CAGR %	11.92	17.48	18.45	14.27	0.26
Capital Expenditures, 5 Yr. CAGR %	-1.06	6.3	12.71	5.12	4.35
Levered Free Cash Flow, 5 Yr. CAGR %	19.5	21.25	23.53	10.05	-1.49
Unlevered Free Cash Flow, 5 Yr. CAGR %	20.03	21.4	23.81	11.22	-1.45
Dividend Per Share, 5 Yr. CAGR %	1.3	9.49	11.28	11.28	11.63